Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03599362
Title Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine

pancreatic cancer


Cabiralizumab + Nivolumab

Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
New York University School of Medicine New York New York 10016 United States Details
University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field